Oppenheimer Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$620K Sell
10,562
-1,456
-12% -$61.1K 0.01% 835
2026
Q1
$387K Buy
12,018
+1,884
+19% +$69.7K ﹤0.01% 923
2025
Q4
$427K Sell
10,134
-3,737
-27% -$151K 0.01% 852
2025
Q3
$476K Buy
+13,871
New +$398K 0.01% 910
2024
Q3
Sell
-9,333
Closed -$202K 1207
2024
Q2
$202K Sell
9,333
-37
-0.4% -$778 ﹤0.01% 1081
2024
Q1
$208K Sell
9,370
-315
-3% -$7.68K ﹤0.01% 1032
2023
Q4
$266K Sell
9,685
-243
-2% -$5.87K ﹤0.01% 1020
2023
Q3
$222K Sell
9,928
-83
-0.8% -$2.13K ﹤0.01% 1027
2023
Q2
$255K Sell
10,011
-468
-4% -$11.3K ﹤0.01% 1004
2023
Q1
$234K Sell
10,479
-564
-5% -$13.6K ﹤0.01% 1021
2022
Q4
$262K Sell
11,043
-855
-7% -$19.9K ﹤0.01% 996
2022
Q3
$198K Sell
11,898
-201
-2% -$4.52K ﹤0.01% 1055
2022
Q2
$241K Sell
12,099
-279
-2% -$5.64K ﹤0.01% 1028
2022
Q1
$342K Sell
12,378
-311
-2% -$8.89K ﹤0.01% 1001
2021
Q4
$523K Sell
12,689
-427
-3% -$18.9K 0.01% 948
2021
Q3
$609K Sell
13,116
-271
-2% -$11.8K 0.01% 886
2021
Q2
$536K Sell
13,387
-89
-0.7% -$3.81K 0.01% 930
2021
Q1
$724K Sell
13,476
-413
-3% -$23.8K 0.01% 823
2020
Q4
$680K Sell
13,889
-1,353
-9% -$62.7K 0.01% 801
2020
Q3
$495K Sell
15,242
-278
-2% -$8.84K 0.01% 815
2020
Q2
$401K Buy
15,520
+369
+2% +$9.19K 0.01% 844
2020
Q1
$368K Buy
15,151
+140
+0.9% +$3.52K 0.01% 817
2019
Q4
$419K Buy
15,011
+1,743
+13% +$45.1K 0.01% 871
2019
Q3
$318K Sell
13,268
-221
-2% -$5.88K 0.01% 924
2019
Q2
$385K Buy
13,489
+4,838
+56% +$121K 0.01% 885
2019
Q1
$216K Sell
8,651
-4,799
-36% -$91.6K ﹤0.01% 1017
2018
Q4
$169K Buy
+13,450
New +$159K ﹤0.01% 1053

Other funds holding VCYT

Oppenheimer Asset Management's VCYT Position: Q2 2026 in Review

Oppenheimer Asset Management reduced its Veracyte (VCYT) stake by 12% in Q2 2026, selling an estimated $61.1K and leaving 10,562 shares worth $620K. The position accounts for 0.01% of the portfolio, ranked #835.

Oppenheimer Asset Management first reported a position in VCYT in Q4 2018 and has held it in 27 quarters since. The position peaked at $724K in Q1 2021. 151 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Oppenheimer Asset Management held 10,562 shares of Veracyte worth $620K as of Q2 2026.
  • Oppenheimer Asset Management sold 1,456 Veracyte shares in Q2 2026, an estimated $61.1K.
  • Veracyte made up 0.01% of Oppenheimer Asset Management's portfolio in Q2 2026, its #835 holding.
  • Oppenheimer Asset Management first reported a position in Veracyte in Q4 2018 and has held it in 27 quarters since.
  • Oppenheimer Asset Management's Veracyte position peaked at $724K in Q1 2021.
  • 151 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.